Of course he doesn’t. The stunning thing is his inability to truly capitalize on this bull run. I don’t see how he could be happy chasing pennies, when there are so many other OTC names that have not only converts, but NO remarkable revenue, that are able to be valued in upwards of 100s of millions of $.